Kristin R. Muessig

A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation

Jessica Ezzell Hunter, Stephanie A. Irving, Leslie G. Biesecker et al. · Genetics in Medicine · 2016 · 152 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators

Jennifer L. Schneider, James V. Davis, Tia L. Kauffman et al. · Genetics in Medicine · 2015 · 49 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Evidence‐based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group

Elizabeth M. Webber, Jessica Ezzell Hunter, Leslie G. Biesecker et al. · Human Mutation · 2018 · 46 citations

Life Sciences, Genetics, Molecular Genetics +13

Returning negative results to individuals in a genomic screening program: lessons learned

Rita M. Butterfield, James P. Evans, Christine Rini et al. · Genetics in Medicine · 2018 · 40 citations · Full text

Medicine, Genetics, Molecular Genetics +14

Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers

Jessica Ezzell Hunter, Jamilyn M. Zepp, Mari J. Gilmore et al. · Cancer · 2015 · 37 citations · Full text

Medicine, Oncology, Preventive Medicine +17